ESR1 and breast cancer: For instance, the progression of luminal-type BC, which is hormone receptor-positive, estrogen receptor (ER)-positive and/or progesterone receptor (PgR)-positive, and human epidermal growth factor receptor 2 (HER2)-negative is usually slow.